Condition
Sinus Disease
Total Trials
5
Recruiting
2
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed2
Recruiting2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05607888Recruiting
Prospective Study of Sinonasal and Skull-base Tumours Management
NCT05454072Not ApplicableActive Not Recruiting
Microbiota Transfer for Chronic Rhinosinusitis
NCT06456255Phase 2RecruitingPrimary
Bupivacaine and Epinephrine Injection Study
NCT06812676Not ApplicableCompletedPrimary
Virtual Reality Induced Analgesia for Nasal Procedures
NCT05596084Not ApplicableCompletedPrimary
Comparison of the Use of Bovine Bone Graft and Titanium-Platelet Rich Fibrin in Maxillary Sinus Augmentation
Showing all 5 trials